RTI Surgical, Inc. (RTIX)’s Trend Down, Especially After Forming a Bearish Ascending Triangle

May 18, 2018 - By Eva Godbolt

Investors sentiment increased to 1.35 in 2017 Q4. Its up 0.24, from 1.11 in 2017Q3. It is positive, as 9 investors sold RTI Surgical, Inc. shares while 28 reduced holdings. 20 funds opened positions while 30 raised stakes. 42.10 million shares or 1.07% more from 41.65 million shares in 2017Q3 were reported.
4,370 were reported by Us Comml Bank De. 496,514 were accumulated by Geode Cap Ltd. Hightower Advsrs Ltd Liability Corporation owns 11,500 shares for 0% of their portfolio. Rutabaga Management Limited Liability Ma accumulated 556,874 shares. Kopp Advsrs Limited Com holds 905,787 shares or 3.72% of its portfolio. Bnp Paribas Arbitrage Sa has invested 0% in RTI Surgical, Inc. (NASDAQ:RTIX). Moreover, Royal State Bank Of Canada has 0% invested in RTI Surgical, Inc. (NASDAQ:RTIX). Rock Springs Cap Mgmt Limited Partnership invested in 0.36% or 1.95 million shares. Stone Ridge Asset Management Ltd Liability, a New York-based fund reported 60,734 shares. Savings Bank Of America Corporation De has 36,487 shares for 0% of their portfolio. Schwab Charles Investment Mngmt Inc owns 108,300 shares. 10,540 are held by Principal Group Inc. Dimensional Fund Advisors L P accumulated 4.27M shares. Moreover, Caprock Group Inc Inc has 0.01% invested in RTI Surgical, Inc. (NASDAQ:RTIX) for 12,010 shares. Voya Investment Management Llc owns 37,110 shares.

The stock of RTI Surgical, Inc. (RTIX) formed an ascending triangle with $4.19 target or 8.00 % below today’s $4.55 share price. The 8 months triangle pattern indicates high risk for the $288.59 million company. If the $4.19 price target is reached, the company will be worth $23.09M less.
The ascending triangle is a questionable performer despite its reputation as a reliable chart pattern. The ascending triangle has break even failure rate for up and down breakouts of 13% and 11%, respectively. The average rise and decline is 35% and 19%. The throwback or so called pullback rates are: 57% and 49%. The stocks meeting their targets is high for this type of breakout: 75% and 68% percent.

The stock increased 2.25% or $0.1 during the last trading session, reaching $4.55. About 157,527 shares traded or 27.98% up from the average. RTI Surgical, Inc. (NASDAQ:RTIX) has risen 21.33% since May 18, 2017 and is uptrending. It has outperformed by 9.78% the S&P500.

Analysts await RTI Surgical, Inc. (NASDAQ:RTIX) to report earnings on August, 14. They expect $0.02 EPS, 0.00 % or $0.00 from last year’s $0.02 per share. RTIX’s profit will be $1.27 million for 56.88 P/E if the $0.02 EPS becomes a reality. After $0.01 actual EPS reported by RTI Surgical, Inc. for the previous quarter, Wall Street now forecasts 100.00 % EPS growth.

More news for RTI Surgical, Inc. (NASDAQ:RTIX) were recently published by: Seekingalpha.com, which released: “RTI Surgical’s (RTIX) CEO Camille Farhat on Q1 2018 Results – Earnings Call Transcript” on May 05, 2018. Streetinsider.com‘s article titled: “RTI Surgical (RTIX) Reports In-Line Q1 EPS, Beats on Revenues; Affirms FY18 Guidance” and published on May 03, 2018 is yet another important article.

RTI Surgical, Inc., together with its subsidiaries, designs, develops, makes, and distributes orthopedic and other surgical implants for use in various surgical procedures worldwide. The company has market cap of $288.59 million. The firm provides natural tissue implants, as well as metal and synthetic implants for the treatment of spinal and other orthopedic disorders. It has a 81.25 P/E ratio. It processes donated human musculoskeletal and other tissues, including bone, cartilage, tendons, ligaments, fascia lata, pericardium, sclera, cornea, and dermal tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

RTI Surgical, Inc. (NASDAQ:RTIX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: